Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem is forecasted to see strong sequential growth in its Human Nutrition and Health (HNH) segment, driven by continued strength in the segment and favorable geopolitical conditions. The company's cash flow and net debt position are also solid indicators of its strong financial positioning. Additionally, Balchem's HNH segment is expected to benefit from a lack of tariffs on its products, as well as the growing demand for its vitamin K2 and choline-based products. The company's margin performance remains robust and its valuation metrics are expected to remain stable, maintaining a positive outlook for investors.

Bears say

Balchem is facing risks such as slower growth, potential inflation, and the possibility of failure with their partner Curemark's autism drug candidate. Along with these risks, Balchem may also face disruptions to their European business. It is also important to note that Balchem's current valuation is based on a comparable universe-derived forward P/E multiple approach and is subject to change.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.